Releases
Found 41434 articles
FDA Rebuffs Sobi Gout Drug Over Manufacturing Concerns
The U.S. Food and Drug Administration has issued a Complete Response Letter to Sobi regarding its application for NASP, a novel treatment for uncontrolled gout. While the regulator pointed to deficiencies in manufacturing controls and contract facilities, it notably raised no objections regarding the drug's clinical safety or efficacy.
FDA Rebuffs Sobi Gout Drug Over Manufacturing Controls
The U.S. Food and Drug Administration has issued a complete response letter regarding Sobi’s Biologics License Application for NASP, an investigational treatment for uncontrolled gout. While the agency requested additional data on manufacturing and facility controls, it raised no objections concerning the drug’s clinical safety or therapeutic efficacy.
AES Stockholders Approve $10.7 Billion Acquisition by Consortium
With 97.92% of votes cast in favor, shareholders of The AES Corporation have cleared the path for a $10.7 billion buyout by a consortium led by Global Infrastructure Partners and EQT. The deal, which values the energy giant at $33.4 billion including debt, marks a pivotal shift for the Arlington-based utility.
Fannie Mae Reports May 2026 Mortgage Portfolio Performance
Fannie Mae’s latest monthly summary, released June 26 in Washington, provides a granular look at the organization’s mortgage-backed securities and portfolio activity through the end of May 2026. The report offers key benchmarks for investors tracking interest rate risk measures and serious delinquency rates across the lender's primary assets.
Uranium Royalty Corp. Shareholders Face July Vote on US$1.14 Billion Deal
Uranium Royalty Corp. has initiated the formal process for shareholders to approve a massive US$1.14 billion plan of arrangement, setting a July 20, 2026, meeting in Vancouver to finalize the acquisition of significant trona royalty assets from the Sweetwater Investors, a subsidiary of the Ontario Teachers' Pension Plan.
Veritone Investors Face July Deadline in Securities Class Action
Investors who acquired Veritone, Inc. securities between October 14, 2025, and April 14, 2026, face a July 20, 2026, deadline to seek lead plaintiff status in a federal class action lawsuit. The litigation centers on allegations that the company misclassified revenue and maintained inadequate financial reporting controls.
Erasca Shareholders Face Securities Fraud Class Action Deadline
Investors who incurred significant financial losses in Erasca, Inc. have until August 10, 2026, to seek appointment as lead plaintiff in a pending securities fraud class action. The lawsuit centers on allegations that the company misled shareholders regarding its drug development processes and potential legal liabilities.
Via Transportation Investors Face Securities Fraud Class Action
Investors who incurred significant losses following Via Transportation’s September 2025 initial public offering have until August 10, 2026, to seek lead plaintiff status. The Law Offices of Howard G. Smith is currently organizing a class action lawsuit against the company, alleging that leadership misled shareholders regarding critical business metrics.
WHO Outlines New Roadmap for Global Newborn Health
Birth defects currently account for nearly eight percent of deaths among children under five, prompting a new World Health Organization framework to integrate early screening and long-term care. Released ahead of International Neonatal Screening Day, the report urges low- and middle-income countries to transition from isolated testing to comprehensive health systems.
Lucid Group Faces Securities Fraud Class Action Over Gravity Deliveries
Investors who incurred significant financial losses in Lucid Group, Inc. stock now have a narrow window to seek lead plaintiff status in a pending securities fraud class action. The Law Offices of Howard G. Smith issued the alert, setting a firm deadline of July 28, 2026, for potential participants to come forward.
CIOs Face Renewed Pressure to Justify IT Spending Through Better Data
Chief Information Officers are increasingly struggling to translate fragmented financial data into clear business value. As scrutiny over technology budgets intensifies, a new framework from Info-Tech Research Group aims to replace opaque spreadsheets with a structured taxonomy, helping IT leaders defend their investments to skeptical enterprise stakeholders.
Frost & Sullivan Names 2026 Visionary Growth Leadership Honorees
Thirty-five global enterprises, ranging from NVIDIA and Visa to Uniqlo and Waste Connections, earned the 2026 Visionary Growth Leadership recognition this week. The award highlights organizations that integrate sustainable development and societal impact into their core business strategies, moving beyond traditional profit-focused performance metrics.
Revision Skincare Names Marco Ficarelli Global Growth Chief
Dallas-based Revision Skincare has tapped industry veteran Marco Ficarelli as its new Chief Global Growth Officer to spearhead international expansion. Effective June 22, the appointment signals a shift toward aggressive scaling in digital commerce and market-specific commercial strategies for the physician-dispensed brand.
Clark Capital Management Wins Dual InvestmentNews Honors
Philadelphia-based Clark Capital Management Group secured two major accolades at the recent InvestmentNews Awards in New York City, winning both the Prudential Advisors Award for Asset Manager of the Year and the Thrivent Award for Excellence in Philanthropy and Community Service.
Daniel D. King Named Fellow of the American Academy of Nursing
The American Academy of Nursing has selected Daniel D. King, an associate professor at Rosalind Franklin University of Medicine and Science, for induction as a Fellow. This honor recognizes his career-long contributions to perioperative safety, health equity, and the development of standardized tools for patient risk assessment.
Microsoft Facing Securities Fraud Lawsuit Over AI Product Performance
Investors who suffered financial losses through Microsoft Corporation between May 2025 and January 2026 are being sought to lead a pending securities fraud class action. The Law Offices of Frank R. Cruz announced the deadline for potential lead plaintiffs to join the litigation is August 11, 2026.
Investors Eye Lead Role in Zoetis Securities Fraud Suit
Investors who sustained financial losses tied to Zoetis Inc. stock now have until July 27, 2026, to seek lead plaintiff status in a securities fraud class action. The litigation, spearheaded by Glancy Prongay & Murray LLP, targets alleged misrepresentations regarding the company’s flagship veterinary product performance and market positioning.
CABEI Approves $3 Billion Capital Boost to Secure Long-Term Growth
Meeting in Oviedo, Spain, the CABEI Board of Governors authorized a Ninth Capital Increase, raising the institution's total capital from $7 billion to $10 billion. This strategic maneuver aims to bolster the bank’s financial footing and expand its capacity to fund large-scale regional development projects across its member nations.
Curaleaf Sets August 5 Date for Second Quarter Earnings Call
Stamford-based cannabis producer Curaleaf Holdings will disclose its financial and operating results for the second quarter on August 5, 2026. The company intends to release its performance data following the close of market trading, initiating a conference call and audio webcast for investors and analysts at 5:00 p.m. ET.
Investors Eye Lead Role in Calix Securities Fraud Class Action
Investors who incurred financial losses holding Calix, Inc. stock now have until July 27, 2026, to seek appointment as lead plaintiff in a pending securities fraud lawsuit. The class action centers on allegations that the company obscured critical supply chain vulnerabilities that ultimately pressured profit margins.
Samaritan's Purse Deploys Field Hospital to Earthquake-Stricken Venezuela
More than 500 people are dead and 3,000 injured following a series of catastrophic earthquakes in Venezuela. Samaritan’s Purse is mobilizing its 767 cargo aircraft to transport an emergency field hospital and vital supplies to the region, aiming to provide immediate medical intervention for thousands left without access to care.
Monteverde & Associates Launches Inquiry Into Synaptics-onsemi Merger
Shareholders of Synaptics Incorporated are facing scrutiny over the company’s proposed acquisition by onsemi, as New York-based law firm Monteverde & Associates PC announced a formal investigation into the deal. The transaction currently values each Synaptics share at 1.350 shares of onsemi common stock, prompting questions regarding equitable compensation.
Monteverde & Associates Launches Investigation into Bio-Techne Sale
Shareholders of Bio-Techne Corporation are facing scrutiny over the company’s proposed acquisition by Merck KGaA, with the New York-based law firm Monteverde & Associates PC questioning the fairness of the $73.00 per share cash offer currently on the table for investors.
Fragrance Industry Veteran Jack Corley Announces Retirement
After a 45-year career defined by commercial innovation and a commitment to sustainable sourcing, Jack Corley is stepping down from his role as Chief Sales and Marketing Officer at Custom Essence. The industry veteran leaves behind a legacy of growth and mentorship that spans several major fragrance houses.
Forever Funding Shifts Charity to Merchant Processing Streams
As U.S. charitable giving hits $592.5 billion, nonprofits are grappling with donor fatigue and the diminishing returns of traditional fundraising. Savannah-based Forever Funding is countering this trend by rerouting merchant credit card processing fees into recurring revenue streams for local causes, bypassing the need for direct consumer solicitations.
Zawa Debuts AI Reel Maker to Automate Social Commerce Video Production
Los Angeles-based design platform Zawa has launched an AI-driven tool designed to convert static product photography into short-form marketing videos. By automating the production process for platforms like TikTok and Instagram, the software aims to help e-commerce teams bypass traditional studio bottlenecks and rapidly scale their creative content testing.
Peabody Energy Investors Face August Deadline in Securities Lawsuit
Investors who purchased Peabody Energy securities between October 14, 2024, and May 4, 2026, face an August 24, 2026, deadline to seek the role of lead plaintiff in a federal class action lawsuit, according to a notice issued by the law firm Faruqi & Faruqi, LLP.
FS KKR Capital Investors Face July 6 Deadline in Fraud Litigation
Investors who incurred financial losses holding FS KKR Capital Corp. stock between May 2024 and February 2026 now have a closing window to serve as lead plaintiffs in a pending securities fraud class action. The Law Offices of Frank R. Cruz is spearheading the effort to hold the company accountable.
Scientology Network Launches Drug Prevention Marathon
Nearly 600,000 lives are lost to drug use annually, a grim statistic driving the Scientology Network to dedicate its June 26 broadcast to global prevention efforts. The special marathon highlights the Foundation for a Drug-Free World, showcasing volunteers who distribute educational materials to youth and families across 198 nations.
Nano-X Investors Face August Deadline in Securities Fraud Class Action
Investors who incurred financial losses holding Nano-X Imaging Ltd. stock between March 2025 and April 2026 have until August 11, 2026, to apply as lead plaintiffs in a securities fraud lawsuit filed by the Law Offices of Frank R. Cruz.